Efficacy of cilostazol in canine bradyarrhythmia

Recently, cilostazol, a phosphodiesterase III inhibitor, has been described as alternative medical treatment for canine bradyarrhythmia in cases for which pacemaker implantation was not indicated or available. In this retrospective study, we investigated the use and efficacy of cilostazol in dogs wi...

Full description

Bibliographic Details
Main Authors: Takahiro Ohmori, Yuri Matsumura, Aritada Yoshimura, Shohei Morita, Hiroshi Hasegawa, Daiki Hirao, Ryuji Fukushima
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.954295/full